Literature DB >> 8152812

Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.

A A Beg1, A S Baldwin.   

Abstract

NF-kappa B is an inducible transcription factor that regulates the expression of numerous genes involved in immune and inflammation responses and in cellular growth control. Typically, NF-kappa B is localized in the cytoplasm complexed with members of the I kappa B family. The most well characterized form of NF-kappa B is comprised of a heterodimer of a 50 kD (p50/NFKB1) and a 65 kD (p65/RelA) protein. This heterodimeric protein was thought to be primarily responsible for transcriptional regulation of target genes. However, recent studies have led to the identification of other kappa B binding proteins such as c-Rel, RelB and p52 (NFKB2/lyt-10) although their role in gene regulation has been less clear. Here, using gel mobility shift assays as well as a highly sensitive DNA-protein crosslinking assay, we provide evidence for the existence of multiple tumor necrosis factor (TNF)- inducible kappa B binding complexes containing various members of the NF-kappa B/Rel family, namely p50 and p65 as well as the c-Rel and p52 oncoproteins. Dimeric complexes containing various combinations of these proteins appear rapidly in nuclei of TNF-alpha-stimulated cells and include, along with a p50-p65 heterodimer, p50-c-Rel, p65-c-Rel, p52-c-Rel and p52-p65 complexes. The presence of multiple inducible complexes containing distinct combinations of NF-kappa B/Rel family members indicate that specific kappa B responsive genes may be regulated in an NF-kappa B subunit-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152812

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.

Authors:  Hai Lu; Xinping Yang; Praveen Duggal; Clint T Allen; Bin Yan; Jonah Cohen; Liesl Nottingham; Rose-Anne Romano; Satrajit Sinha; Kathryn E King; Wendy C Weinberg; Zhong Chen; Carter Van Waes
Journal:  Cancer Res       Date:  2011-09-20       Impact factor: 12.701

2.  The LMP1 promoter can be transactivated directly by NF-kappaB.

Authors:  Constantinos Demetriades; George Mosialos
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

3.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

4.  Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members.

Authors:  S Ma; L Rao; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1997

5.  Gene transcription through activation of G-protein-coupled chemoattractant receptors.

Authors:  R D Ye; Z Pan; V V Kravchenko; D D Browning; E R Prossnitz
Journal:  Gene Expr       Date:  1996

6.  Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.

Authors:  Kyle D Weaver; Susan Yeyeodu; James C Cusack; Albert S Baldwin; Matthew G Ewend
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

Review 7.  Moving towards a systems-based classification of innate immune-mediated diseases.

Authors:  Sinisa Savic; Emily A Caseley; Michael F McDermott
Journal:  Nat Rev Rheumatol       Date:  2020-02-27       Impact factor: 20.543

8.  Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

Authors:  P L Jones; D Ping; J M Boss
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.

Authors:  T Mitchell; B Sugden
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.

Authors:  S C Dollard; S Gummuluru; S Tsang; P N Fultz; S Dewhurst
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.